source
- Setbacks for Novartis; Anthropic looks for a dealmaker; and moreWelcome back to another edition of Endpoints Weekly! While it is still technically summer, the season is starting to turn now that we’re past Labor Day. It will be a sprint to Thanksgiving, and we’…Endpoints · 22m ago↗ source
- Yarrow Bioscience raises $150M as AbbVie reports positive menstrual migraine trial resultsYarrow Bioscience, based in New Haven, announced pricing of a $150 million equity offering at $26 per share, roughly $2.50 below the previous closing price. The capital raise will provide addition…